Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06381232 · ClinicalTrials.gov registry record

Collection and Analyses of Physiological, Physical, and Molecular Data From a Diverse Population

A clinical trial of Wellness and General Health, sponsored by Viome.

Recruiting
Registry status
20,000
Enrollment target
1
Study location

NCT06381232: Recruiting study of Wellness and General Health, sponsored by Viome.

NCT06381232 is a study of Wellness and General Health that is actively recruiting participants, run by Viome. The registered enrollment target is 20,000 participants, above the 145-participant average among 5 other Wellness trials with a reported enrollment target (13693% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06381232, a study of Wellness and General Health, is actively recruiting participants, sponsored by Viome.

RECRUITING
Registry status
20,000 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to collect and analyze physiological, physical, and molecular data from a diverse population to increase our understanding of how such parameters are associated with health and disease.

Primary Outcome

We measure thousands of transcript levels in multiple clinical samples. The primary outcome measures are changes in quantitative gene expression, microbial or human, as a result of transitioning from a healthy state to a disease.

Conditions Studied

Interventions

  • OTHER No Intervention

Study Locations (1)

Washington

  • Viome Life Sciences - Bothell

Trial Details

FieldValue
Enrollment Target 20,000 participants
Start Date 2018-07-23
Est. Completion 2028-07-23
Viome

18 total trials

What NCT06381232 shows while recruiting

NCT06381232 is an observational study that tracks outcomes without assigning an intervention. Its 20,000 participants enrollment target places it among the larger protocols in the corpus, above the 145-participant average among 5 other Wellness trials with a reported enrollment target (13693% higher).

The record links to 2 conditions, with Wellness appearing as the primary indexed condition, and to 1 intervention - of which No Intervention is the first listed.

NCT06381232 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT06381232 about?

NCT06381232 is a clinical study titled "Collection and Analyses of Physiological, Physical, and Molecular Data From a Diverse Population". The purpose of the study is to collect and analyze physiological, physical, and molecular data from a diverse population to increase our understanding of how such parameters are associated with health and disease.

What is the current status of trial NCT06381232?

This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 2018-07-23. Estimated completion is 2028-07-23.

What conditions does trial NCT06381232 study?

This clinical trial studies the following conditions: Wellness, General Health.

What interventions are being tested in trial NCT06381232?

The interventions under investigation include: No Intervention (OTHER).

Who is sponsoring clinical trial NCT06381232?

This trial is sponsored by Viome, which has 18 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06381232 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Wellness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00271180 · 20,000 participants

    Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

  • NCT00830557 · 20,000 participants

    Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

  • NCT00900471 · 20,000 participants

    Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors

  • NCT02735707 · 20,000 participants · Phase 3

    Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06381232, the US trial registry maintained by the National Library of Medicine. NCT06381232 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.